Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats

American Journal of Hypertension

Volumn 11, Issue 5, 1998, Pages 554-562

  Li, Jin S ^a   Turgeon, André ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Blood vessels; Endothelin 1; Vascular remodeling

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATRASENTAN; DARUSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SODIUM RETENTION; TREATMENT OUTCOME;

EID: 0031865858     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00405-6     Document Type: Article

References (36)

1. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
2. Bobik A, Grooms A, Millar JA, et al: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990;258:C408-C415.
3. Chua BHL, Krebs CJ, Chua CC, Diglio Ca: Endothelin stimulates protein synthesis in smooth muscle cells. Am J Physiol 1992;262:E412-E416.
4. Schiffers PMH, Fazzi GE, Van Ingen Schenau D, De Mey JGR: Effects of candidate autocrine and paracrine mediators on growth responses in isolated rat arteries. Arterioscler Thromb 1994;14:420-426.
5. Schiffrin EL: Endothelin, potential role in hypertension and vascular hypertrophy. Brief review. Hypertension 1995;25:1135-1143.
6. Larivière R, Thibault G, Schiffrin EL: Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993;21:294-300.
7. Larivière R, Day R, Schiffrin EL: Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1993;21:916-920.
8. Day R, Larivière R, Schiffrin EL: In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 1995;8: 294-300.
9. Schiffrin EL, Larivière R, Li J-S, et al: Deoxycorticosterone acetate plus salt induce overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension 1995;25(part 2):769-773.
10. Li JS, Larivière R, Schiffrin EL: Effect of a nonselective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Evidence of a role of endothelin in vascular hypertrophy. Hypertension 1994;24:183-188.
11. Bird JE, Moreland S, Waldron TL, Powell JR: Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension 1995;25:1191-1195.
12. B endothelin receptor antagonist, in DOCA-salt spontaneously hypertensive rats. Br J Pharmacol 1995;115:1377-1381.
13. Li JS, Schürch W, Schiffrin EL: Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats. Am J Hypertens 1996;9: 803-811.
14. De Nucci G, Thomas R, D'Orléans-Juste P, et al: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85: 9797-9800.
15. A-selective receptor antagonist. J Pharmacol Exp Ther 1996;276:473-481.
16. Riechers H, Albrecht HP, Amberg W, et al: Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists. J Med Chem 1996;39:2123-2128.
17. A-receptor antagonist inhibits neointima formation induced by endothelial injury. Pharm Pharmacol Lett 1996;6:90-92.
18. Ormsbee HS, Ryan CF: Production of hypertension with deoxycorticosterone acetate-impregnated silicone rubber implants. J Pharmacol Sci 1973;62:255-257.
19. Sventek P, Turgeon A, Schiffrin EL: Vascular endothelin-1 gene expression and effect of blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats. Circulation 1997;95:240-244.
20. A-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Br J Pharmacol 1997;121:935-940.
21. Li J-S, Schiffrin EL: Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995;25(Part 1):495-500.
22. Li J-S, Schiffrin EL: Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats. J Hypertens 1995;13:647-652.
23. Li J-S, Schiffrin EL: Effect of calcium channel blockade or angiotensin converting enzyme inhibition on structure of coronary, renal and other small arteries in SHR. J Cardiovasc Pharmacol 1996;28:68-74.
24. Deng LY, Schiffrin EL: Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol 1992;262:H1782-H1787.
25. Schiffrin EL, Larivière R, Li J-S, Sventek P: Enhanced expression of endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J Vase Res 1996;33:235-248.
26. Karam H, Heudes D, Gonzales M-F, et al: Respective roles of humoral factors and blood pressure in aortic remodeling of DOCA-salt hypertensive rats. Am J Hypertens 1996;9:991-998.
27. ω-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 1996;14:1331-1339.
28. Larivière R, Deng LY, Day R, et al: Increased endothelin-1 expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat. J Mol Cell Cardiol 1995;27:2123-2131.
29. B endothelin receptor antagonist bosentan. Can J Physiol Pharmacol 1995;73:390-398.
30. Batra Vk, McNeil JR, Xu Y, et al: ETB receptors on aortic smooth muscle cells of spontaneously hypertensive rats. Am J Physiol (Cell Physiol) 1993;264:C479-C484.
31. Mulvany MJ, Baumbach GL, Aalkjaer C, Et al: Vascular remodelling (letter). Hypertension 1996;28:505-506.
32. Baumbach GL, Heistad DD: Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989; 13:968-972.
33. Hajdu MA, Baumbach GL: Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol 1994;266:H1027-H1033.
34. Chillon JM, Heistad DD, Baumbach GL: Effects of endothelin receptor inhibition on cerebral arterioles in hypertensive rats. Hypertension 1996;27:794-798.
35. Wagner OF, Christ G, Wojta J, et al: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
36. Löffler B-M, Breu V, Clozel M: Effect of endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett 1993;333:108-110.